Regenxbio (RGNX) Other Non-Current Assets (2014 - 2025)

Regenxbio's Other Non-Current Assets history runs 12 years deep, the most recent figure standing at $4.6 million for Q4 2025.

• In Q4 2025, Other Non-Current Assets rose 15.33% year-over-year to $4.6 million; the TTM figure through Dec 2025 stood at $4.6 million (up 15.33% YoY), while the FY2025 annual figure was $4.6 million, up 15.33% from the prior year.
• Other Non-Current Assets was $4.6 million for Q4 2025 at Regenxbio, up from $4.3 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $4.8 million in Q4 2023 to a low of $1.3 million in Q1 2021.
• Historically, Other Non-Current Assets has averaged $2.5 million across 5 years, with a median of $2.0 million in 2021.
• The sharpest annual moves came in 2023 and 2024: Other Non-Current Assets surged 136.8% in 2023, then fell 16.79% in 2024.
• A 5-year view of Other Non-Current Assets shows it stood at $2.0 million in 2021, then changed by 0.0% to $2.0 million in 2022, then soared by 136.8% to $4.8 million in 2023, then slipped by 16.79% to $4.0 million in 2024, then rose by 15.32% to $4.6 million in 2025.
• The last three Other Non-Current Assets figures came in at $4.6 million (Q4 2025), $4.3 million (Q3 2025), and $1.9 million (Q2 2025), per Business Quant data.